Stay ahead with the latest FDA regulations affecting software-aided adjunctive diagnostic devices for skin lesions. This course provides a comprehensive breakdown of the new class II classification and mandatory special controls, offering actionable steps for manufacturers, sponsors, and regulatory professionals. Discover compliance strategies, clinical validation expectations, and how to avoid costly missteps in bringing innovative diagnostic software to market. Learn directly from regulatory experts and ensure your device meets all FDA requirements for safety, labeling, documentation, and performance.
In this course you will learn the following:
* Understand the scope and intent of the FDA’s final rule for these devices.
* Identify the key special controls and general controls now required by law.
* Outline the steps necessary to achieve and maintain compliance.
* Recognize the legal and regulatory consequences of failing to comply with the new requirements.
